Dr Reddys Laboratories (RDY) Gains from Sales and Divestitures (2009 - 2026)
Dr Reddys Laboratories' Gains from Sales and Divestitures came in at -$387,099 for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$3.53 million a year earlier.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Gains from Sales and Divestitures (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Dr Reddys Laboratories reported Gains from Sales and Divestitures of -$7.34 million; for FY2026 (ended Mar 31, 2026), it came in at $27 million, up 50.0% from FY2025.
- Going back by fiscal year, Gains from Sales and Divestitures was $18 million in FY2025 (+63.6%), $11 million in FY2024, -$3 million in FY2023 and $15 million in FY2022.
- The fiscal Q2 2027 figure represents the highest quarterly Gains from Sales and Divestitures since fiscal Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,242.36 Bn | 1,215.98 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 668.81 Bn | 588.67 Bn | 17.30 Bn |
| 3 | AbbVie | 515.10 Bn | 483.11 Bn | 13.12 Bn |
| 4 | Merck | 362.39 Bn | 325.33 Bn | 13.19 Bn |
| 5 | Novartis Ag | 314.14 Bn | 287.38 Bn | - |
| 6 | Astrazeneca | 291.23 Bn | 265.12 Bn | 13.26 Bn |
| 7 | Amgen | 248.23 Bn | 199.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.43 Bn | 183.54 Bn | 6.73 Bn |
| 9 | Pfizer | 165.78 Bn | 113.13 Bn | 12.56 Bn |
| 10 | Dr Reddys Laboratories | 12.39 Bn | 11.73 Bn | 472.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -387,099.30 |
| Jun 30, 2026 | -3.89 Mn |
| Sep 30, 2025 | -3.53 Mn |
| Jun 30, 2025 | 467,388.46 |
| Sep 30, 2024 | -5.13 Mn |
| Jun 30, 2024 | -203,791.07 |
| Mar 31, 2024 | 21.87 Mn |
| Dec 31, 2023 | -5.66 Mn |
| Sep 30, 2023 | -5.29 Mn |
| Jun 30, 2023 | -97,373.30 |
| Mar 31, 2023 | -3.36 Mn |
| Sep 30, 2022 | 1.12 Mn |
| Jun 30, 2022 | -272,337.14 |
| Mar 31, 2022 | 30.65 Mn |
| Dec 31, 2021 | -333,664.91 |
| Sep 30, 2021 | -15.28 Mn |
| Jun 30, 2021 | -393,295.85 |
| Mar 31, 2021 | -1.10 Mn |
| Dec 31, 2020 | 311,408.66 |
| Sep 30, 2020 | 187,974.77 |
API Access
Dr Reddys Laboratories Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();